Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

280 13 Applications of CpG Motifs from Bacterial DNA in Cancer Immunotherapy
20 Krown, S. E., Friden, G. B., Khansur,
T., et al. Phase I trial with the interferon
inducer polyI:C/poly-l-lysine
(Poly ICL). J Interferon Res 1983; 3:
281±290.
21 Kumar, A.,Yang,Y. L., Flati,V., et al.
Deficient cytokine signaling in mouse
embryo fibroblasts with a targeted deletion
in the PKR gene: role of IRF-1 and
NF-kB. EMBO J 1997; 16: 406±416.
22 Michelson, A. M., Shaool, D. and
Lacour, F. Poly(A).poly(U) as adjuvant
in cancer treatment distribution and
pharmacokinetics in rabbits. Proc Soc
Exp Biol Med 1985; 179: 180±186.
23 Park, S. J., Kim,W. H., Han, K. H., et
al. Adjuvant effect of polyadenylic.polyuridylic
acid on antibody production
of recombinant hepatitis B surface antigen
in mice. Int J Immunopharmacol
1995; 17: 513±516.
24 Lacour, J. Clinical trials using polyadenylic±polyuridylic
acid as an adjuvant
to surgery in treating different human
tumors. J Biol Response Mod 1985; 4:
538±543.
25 Khan, A. L., Richardson, S., Drew, J.,
et al. Polyadenylic±polyuridylic acid enhances
the natural cell-mediated cytotoxicity
in patients with breast cancer
undergoing mastectomy. Surgery 1995;
118: 531±538.
26 Hahm, K. B., Han, K. Y., Kim,W. H.,
et al. Efficacy of polyadenylic.polyuridylic
acid in the treatment of chronic
active hepatitis B. Int J Immunopharmacol
1994; 16: 217±225.
27 Tokunaga, T.,Yamamoto, S. and
Namba, K. A synthetic single-stranded
DNA, poly(dG,dC), induces interferona/b
and -g, augments natural killer activity,
and suppresses tumor growth.
Jpn J Cancer Res 1988; 79: 682±686.
28 Pisetsky, D. S. and Reich, C. F., III.
The influence of base sequence on the
immunological properties of defined
oligonucleotides. Immunopharmacology
1998; 40: 199±208.
29 Suzuki, K., Mori, A., Ishii, K. J., et al.
Activation of target-tissue immune-recognition
molecules by double-stranded
polynucleotides. Proc Natl Acad Sci
USA 1999; 96: 2285±2290.
30 Ishii, K. J., Suzuki, K., Coban, C., et al.
Genomic DNA released by dying cells
induces the maturation of APCs. JImmunol
2001; 167: 2602±2607.
31 Krieg, A. M. CpG motifs in bacterial
DNA and their immune effects. Annu.
Rev. Immunol. 2002; 20: 709±760.
32 Krieg, A. M.,Yi, A. K., Matson, S., et al.
CpG motifs in bacterial DNA trigger direct
B-cell activation. Nature 1995; 374:
546±549.
33 Bird, A. P. CpG islands as gene markers
in the vertebrate nucleus. Trends
Genet 1987; 3: 342±347.
34 Han, J., Zhu, Z., Hsu, C. and Finley,W.
H. Selection of antisense oligonucleotides
on the basis of genomic frequency
of the target sequence. Antisense
Res Dev 1994; 4: 53±65.
35 Krieg, A. M.,Wu, T.,Weeratna, R.,
et al. Sequence motifs in adenoviral
DNA block immune activation by stimulatory
CpG motifs. Proc Natl Acad
Sci USA 1998; 95: 12631±12636.
36 Chen,Y., Lenert, P.,Weeranta, R.,
et al. Identification of methylated CpG
motifs as inhibitors of the immune stimulatory
CpG motifs. Gene Ther 2001;
8: 1024±1032.
37 Brown,W. C., Estes, D. M., Chantler,
S. E., Kegerreis, K. A. and
Suarez, C. E. DNA and a CpG oligonucleotide
derived from Babesia bovis are
mitogenic for bovine B cells. Infect Immun
1998; 66: 5423±5432.
38 Sun, S., Cai, Z., Langlade-Demoyen, P.,
et al.DualfunctionofDrosophila cells as
APCs for naive CD8 + Tcells: implications
for tumor immunotherapy. Immunity
1996; 4: 555±564.
39 Sun, S., Beard, C., Jaenisch, R.,
Jones, P. and Sprent, J. Mitogenicity
of DNA from different organisms for
murine B cells. J Immunol 1997; 159:
3119±3125.
40 Dempsey, P. W., Allison, M. E., Akkaraju,
S., Goodnow, C. C. and
Fearon, D. T. C3d of complement as
a molecular adjuvant: bridging innate
and acquired immunity. Science 1996;
271: 348±350.
41 Medzhitov, R. and Janeway, C. A., Jr.
Innate immunity: impact on the adap-